In our studies blocking NFkB with a chemical inhibitor or shRNA was sufficient for the reestablishment of basal polarity in malignant cells; conversely in all conditions where malignant breast cancer cells were ‘reverted’, NFkB levels were decreased. Here, NFKB1 is linked to breast cancer.